Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Momokazu Gotoh

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Development of continence care system for the elderly in a communityMomokazu Gotoh
The Journal of Urology|August 22, 2024
Reply: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialMomokazu Gotoh
The Journal of Urology|October 22, 2011
The mechanisms underlying α1-adrenoceptor antagonists and modulation of bladder function: an emerging role for changes in perfusionMomokazu Gotoh
Nagoya Journal of Medical Science|March 21, 2008
Quality of life assessment for patients with urinary incontinenceMomokazu Gotoh
Hinyokika Kiyo. Acta Urologica Japonica|October 19, 2005
[Surgery (TUR-P) as a recommended initial treatment modality for the presented case]Momokazu Gotoh
Urology|July 20, 2015
Reply: To PMID 26189139Yoshihisa Matsukawa, Momokazu Gotoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Changes in the lower urinary tract function after radical prostatectomy]Momokazu Gotoh, Yoshihisa Matsukawa
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2019
Factors contributing to the efficacy of two add-on therapies of fesoterodine or mirabegron to silodosin monotherapy for persistent overactive bladder in men with lower urinary tract symptomsYoshihisa Matsukawa, Momokazu Gotoh
International Journal of Urology : Official Journal of the Japanese Urological Association|May 17, 2013
Editorial comment to regenerative medicine as a new therapeutic strategy for lower urinary tract dysfunctionTokunori Yamamoto, Momokazu Gotoh
BJU International|April 3, 2009
Symptom severity and patient perceptions in overactive bladder: how are they related?Yukio Homma, Momokazu Gotoh
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Development of continence care system for the elderly in a communityMomokazu Gotoh
The Journal of Urology|August 22, 2024
Reply: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialMomokazu Gotoh
The Journal of Urology|October 22, 2011
The mechanisms underlying α1-adrenoceptor antagonists and modulation of bladder function: an emerging role for changes in perfusionMomokazu Gotoh
Nagoya Journal of Medical Science|March 21, 2008
Quality of life assessment for patients with urinary incontinenceMomokazu Gotoh
Hinyokika Kiyo. Acta Urologica Japonica|October 19, 2005
[Surgery (TUR-P) as a recommended initial treatment modality for the presented case]Momokazu Gotoh
Urology|July 20, 2015
Reply: To PMID 26189139Yoshihisa Matsukawa, Momokazu Gotoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Changes in the lower urinary tract function after radical prostatectomy]Momokazu Gotoh, Yoshihisa Matsukawa
International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2019
Factors contributing to the efficacy of two add-on therapies of fesoterodine or mirabegron to silodosin monotherapy for persistent overactive bladder in men with lower urinary tract symptomsYoshihisa Matsukawa, Momokazu Gotoh
International Journal of Urology : Official Journal of the Japanese Urological Association|May 17, 2013
Editorial comment to regenerative medicine as a new therapeutic strategy for lower urinary tract dysfunctionTokunori Yamamoto, Momokazu Gotoh
BJU International|April 3, 2009
Symptom severity and patient perceptions in overactive bladder: how are they related?Yukio Homma, Momokazu Gotoh
Pageof 26